Table 5 |
||||||
|
Plasma lipoproteins, glucose, insulin, folate and homocysteine concentrations during the dietary interventions1 |
||||||
|
Baseline |
Week 4 |
Week 8 |
Week 12 |
Change3 |
||
|
|
||||||
|
Total Cholesterol mmol/L |
VLCARB |
5.92 ± 0.21 |
5.38 ± 0.20 |
5.68 ± 0.29 |
5.82 ± 0.26 |
-0.09 ± 0.20 |
|
VLF |
5.64 ± 0.23 |
4.83 ± 0.20 |
4.94 ± 0.23 |
5.15 ± 0.26 |
-0.49 ± 0.14 |
|
|
HUF |
6.09 ± 0.23 |
5.11 ± 0.23 |
5.27 ± 0.26 |
5.62 ± 0.24 |
-0.47 ± 0.15 |
|
|
LDL Cholesterol2 mmol/L |
VLCARB |
3.83 ± 0.18 |
3.57 ± 0.21 |
3.89 ± 0.28 |
4.01 ± 0.26 |
0.18 ± 0.18a |
|
VLF |
3.65 ± 0.22 |
3.05 ± 0.18 |
3.16 ± 0.20 |
3.25 ± 0.22 |
-0.40 ± 0.11b |
|
|
HUF |
4.12 ± 0.24 |
3.38 ± 0.20 |
3.54 ± 0.25 |
3.78 ± 0.22 |
-0.34 ± 0.14b |
|
|
ApoB g/L |
VLCARB |
1.01 ± 0.05 |
0.94 ± 0.05 |
1.00 ± 0.05 |
-0.02 ± 0.05 |
|
|
VLF |
0.97 ± 0.05 |
0.85 ± 0.05 |
0.89 ± 0.06 |
-0.07 ± 0.02 |
||
|
HUF |
1.05 ± 0.06 |
0.93 ± 0.06 |
0.99 ± 0.05 |
-0.06 ± 0.02 |
||
|
HDL Cholesterol2 mmol/L |
VLCARB |
1.26 ± 0.05 |
1.27 ± 0.05 |
1.26 ± 0.05 |
1.32 ± 0.05 |
0.06 ± 0.03a |
|
VLF |
1.31 ± 0.07 |
1.18 ± 0.05 |
1.15 ± 0.06 |
1.25 ± 0.06 |
-0.06 ± 0.04b |
|
|
HUF |
1.26 ± 0.05 |
1.15 ± 0.05 |
1.15 ± 0.05 |
1.19 ± 0.04 |
-0.06 ± 0.03b |
|
|
Triacylglycerols2 mmol/L |
VLCARB |
1.83 ± 0.19 |
1.20 ± 0.12 |
1.16 ± 0.10 |
1.11 ± 0.10 |
-0.73 ± 0.12a |
|
VLF |
1.51 ± 0.13 |
1.31 ± 0.10 |
1.38 ± 0.12 |
1.44 ± 0.13 |
-0.06 ± 0.13b |
|
|
HUF |
1.56 ± 0.11 |
1.27 ± 0.12 |
1.29 ± 0.11 |
1.42 ± 0.12 |
-0.15 ± 0.07b |
|
|
Glucose mmol/L |
VLCARB |
5.3 ± 0.1 |
5.2 ± 0.1 |
5.3 ± 0.1 |
5.3 ± 0.1 |
-0.1 ± 0.1 |
|
VLF |
5.3 ± 0.1 |
5.1 ± 0.1 |
5.2 ± 0.1 |
5.3 ± 0.1 |
-0.1 ± 0.1 |
|
|
HUF |
5.4 ± 0.1 |
5.4 ± 0.1 |
5.2 ± 0.1 |
5.2 ± 0.1 |
-0.2 ± 0.1 |
|
|
Insulin2 mU/L |
VLCARB |
10.7 ± 1.1 |
8.2 ± 0.8 |
8.1 ± 1.0 |
7.1 ± 0.8 |
-3.6 ± 0.5a |
|
VLF |
8.6 ± 0.7 |
8.2 ± 0.7 |
7.8 ± 0.8 |
9.9 ± 1.9 |
1.3 ± 1.7b,c |
|
|
HUF |
9.1 ± 0.6 |
9.0 ± 0.6 |
7.9 ± 0.6 |
7.4 ± 0.7 |
-1.7 ± 0.5a,c |
|
|
Folate nmol/L |
VLCARB |
23.13 ± 1.46 |
22.52 ± 1.03 |
-0.61 ± 0.84 |
||
|
VLF |
23.99 ± 1.42 |
27.54 ± 1.10 |
3.54 ± 1.30 |
|||
|
HUF |
23.95 ± 1.32 |
24.83 ± 1.61 |
0.88 ± 1.82 |
|||
|
Homocysteine2 umol/L |
VLCARB |
7.28 ± 0.33 |
7.76 ± 0.39 |
0.56 ± 0.27a |
||
|
VLF |
7.30 ± 0.45 |
6.80 ± 0.34 |
-0.50 ± 31b,c |
|||
|
HUF |
7.14 ± 0.32 |
7.19 ± 0.30 |
-0.04 ± 0.22a,c |
|||
|
C reactive protein mg/L |
VLCARB |
5.27 ± 0.71 |
. |
4.51 ± 0.60 |
-0.76 ± 0.56 |
|
|
VLF |
4.52 ± 0.78 |
3.42 ± 0.70 |
-1.10 ± 0.50 |
|||
|
HUF |
4.52 ± 0.70 |
4.17 ± 0.71 |
-0.35 ± 0.71 |
|||
|
|
||||||
|
1mean ± SEM VLCARB = very low carbohydrate (n = 24) VLF = very low fat (n = 22) HUF = high unsaturated fat (n = 21) 2 Significant main effect of diet using repeated measures ANOVA with time as the within subject factor and diet as the between subject factor after adjustment for weight loss as a covariate (P < 0.05) 3 When significant main effect of diet detected, post hoc analysis was conducted using Tukeys test. Variables with the different superscripts are significantly different from one another (P < 0.05) |
||||||
|
Noakes et al. Nutrition & Metabolism 2006 3:7 doi:10.1186/1743-7075-3-7 |
||||||